142 assets in Head And Neck Cancer

Therapeutic assets addressing Head And Neck Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nepenthe Head And Neck Cancer	Instituto Nacional de Cancer, Brazil	P4	BB (71)
Cis-Diamminedichloroplatinum Ii Head And Neck Cancer	ImmunityBio, Inc.	P3	BB (69)
Lidocaine Head And Neck Cancer	Instituto Nacional de Cancer, Brazil	P3	BB (68)
Carboplatin Head And Neck Cancer	Rapa Therapeutics LLC	P3	BB (67)
Cetuximab Head And Neck Cancer	Pfizer	P3	BB (66)
Cyclophosphamide Head And Neck Cancer	Zelluna Immunotherapy AS	P3	BB (66)
Epirubicin Head And Neck Cancer	Thomas Jefferson University	P3	BB (66)
Pembrolizumab Head And Neck Cancer	Thomas Jefferson University	P3	BB (66)
Gabapentin Head And Neck Cancer	Natalie Lockney	P3	BB (65)
Fluorouracilum Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P3	BB (64)
Docetaxel Head And Neck Cancer	National Cancer Institute (NCI)	P3	B (62)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Head And Neck Cancer	Bolt Biotherapeutics, Inc.	P2	B (62)
Nivolumab Head And Neck Cancer	Fate Therapeutics	P3	B (62)
Durvalumab Head And Neck Cancer	Second Affiliated Hospital of Guangzhou Medical University	P2	B (61)
Atezolizumab Head And Neck Cancer	Centre Georges Francois Leclerc	P2	B (59)
Ipilimumab Head And Neck Cancer	Second Affiliated Hospital of Guangzhou Medical University	P2	B (57)
Sonazoid Head And Neck Cancer	The Netherlands Cancer Institute	P2/3	B (57)
Doxycycline Head And Neck Cancer	M.D. Anderson Cancer Center	P2	B (56)
Dostarlimab Head And Neck Cancer	iTeos Belgium SA	P2	CCC (55)
Palbociclib Head And Neck Cancer	Pfizer	P2	CCC (55)
Immunoglobulin G1 [300-Alanine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Tj004309 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Tj004309 ?-Chain, Dimer Head And Neck Cancer	I-Mab Biopharma US Limited	P2	CCC (54)
Fludarabine Head And Neck Cancer	Zelluna Immunotherapy AS	P1/2	CCC (53)
Pentoxifylline Head And Neck Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Pirfenidone Head And Neck Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Pravastatin Head And Neck Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
(Rs)-Ketoprofen Head And Neck Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Tocopherol Head And Neck Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Zanidatamab Head And Neck Cancer	UNICANCER	P2	CCC (53)
[18f]f-resca-rt4 Head And Neck Cancer	RenJi Hospital	P2/3	CCC (52)
[18F]F-RESCA-T4 Head And Neck Cancer	RenJi Hospital	P2/3	CCC (52)
[68ga]ga-nota-rt4 Head And Neck Cancer	RenJi Hospital	P2/3	CCC (52)
[68ga]ga-nota-t4 Head And Neck Cancer	RenJi Hospital	P2/3	CCC (52)
Fulvestrant Head And Neck Cancer	Pfizer	P2	CCC (51)
had5-hpv vaccine Head And Neck Cancer	ImmunityBio, Inc.	P2	CCC (51)
her3-dxd Head And Neck Cancer	Daiichi Sankyo	P2	CCC (51)
Letrozole Head And Neck Cancer	Pfizer	P2	CCC (51)
Niraparib Head And Neck Cancer	Tempus AI	P2	CCC (51)
Riluzole Head And Neck Cancer	University of California, Irvine	P2	CCC (51)
Vinorelbine Ditartrate Head And Neck Cancer	UNICANCER	P1/2	CCC (51)
[177lu]lu-dpi-4452 Head And Neck Cancer	ITM Oncologics GmbH	P1/2	CCC (48)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Head And Neck Cancer	Natalie Lockney	P1/2	CCC (48)
[68ga]ga-dpi-4452 Head And Neck Cancer	ITM Oncologics GmbH	P1/2	CCC (48)
Entinostat Head And Neck Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
pds01adc Head And Neck Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
scg142 Head And Neck Cancer	SCG Cell Therapy Pte. Ltd.	P1/2	CCC (48)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Head And Neck Cancer	VM Oncology, LLC	P1/2	CC (47)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01 Head And Neck Cancer	Kidney Cancer Research Bureau	P1/2	CC (47)
NC 410 Head And Neck Cancer	NextCure, Inc.	P1/2	CC (47)
SL-28 Head And Neck Cancer	Second Life Therapeutics	P1/2	CC (47)
Trastuzumab Head And Neck Cancer	Fate Therapeutics	P1	CC (47)

Showing 1 to 50 of 142 assets

PreviousPage 1 of 3Next